Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Inetetamab|DRUG: Toripalimab|DRUG: Albumin-Bound Paclitaxel
Sponsor: Chinese Academy of Medical Sciences